Skip to content
Neurology Minute cover art

All episodes

Neurology Minute, 1,000 episodes. Page 7 of 10.

#
Title
601

Transcobalamin Receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency - Part 2

602

Large Language Models for Quality and Efficiency of Neurologic Care - Part 1

603

Transcobalamin receptor Antibodies in Autoimmune Vitamin B12 Central Deficiency

604

Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 1

605

Women History Minute - Marian Molly Putnam

606

Understanding Apathy in Parkinson Disease - Part 2

607

Understanding Apathy in Parkinson Disease - Part 1

608

Paraneoplastic CAMKV Autoimmune Encephalitis

609

Women History Minute - Mary Putnam Jacobi

610

An Angiotensin Receptor Blocker for Hypertension Is Associated With a Reduced Risk for Epilepsy

611

Systematic Review of Individuals with Seropositive MOGAD

612

Epidural Patching Outcomes and Predictors of Benefit in Patients With Suspected CSF Leak

613

Physician as Patient Series - Multiple Sclerosis

614

Physician as Patient Series - Multiple Sclerosis

615

Women History Minute - Ema Gibbs

616

Women History Minute - Marie Joubert

617

Women History Minute - Mary Spink and Alice Bennett

618

Talk with AAN President

619

Highlights of the 2024 European Stroke Organization Conference

620

Association between Radiographic Features of Hypertrophic Pachymeningitis and its Underlying Diagnoses

621

Prospective Study Presents Longitudinal Trajectory of Cognitive Impairment in Patients With Essential Tremor

622

Neurologic Outcomes in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Exposed To Immune Checkpoint Inhibitors

623

Refractory Headache Part 3

624

AAN Brain Health Initiative

625

CSF Metagenomics and Host Transcriptomics of Cryptogenic New-onset Refractory Status Epilepticus

626

Withdrawing Life Support for Patients with Severe Brain Injury

627

Refractory Headache Series Part 2

628

Refractory Headache Series Part 1

629

Mortality in a Danish NMO Cohort

630

Neuromodulation for Primary Headache - Part 6

631

Migraine and Headache Awareness Month

632

Women History Minute - Eliska Klimkova-Deutschova

633

Glucose Control and ICH Risk

634

Cortical Morphology in Migraine

635

Women History Minute - Isabelle Rapin

636

Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Part 2

637

Women History Minute - Mary Anne Guggenheim

638

Post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Part 1

639

Comparing IV Thrombolysis to Endovascular Therapy in Basilar Occlusion

640

Women History Minute - Louise Eisenhardt

641

Neuromodulation for Primary Headache - Part 5

642

Physicians as Patients Series - Inclusivity of Physicians with Disabilities - Part 2

643

Seizure Recurrence in Generalized Epilepsy After Switching Away From Valproate

644

Physicians as Patients Series - Inclusivity of physicians with disabilities - Part 1

645

Updates on the Impact of Sleep Apnea on Cognition and Dementia Risk

646

Study Identifies Disparities in Access to Neurodiagnostic Studies for Drug-Resistant Epilepsy

647

Randomized Trial of Cannabis Extract in Parkinson- Part 2

648

Randomized Trial of Cannabis Extract in Parkinson- Part 1

649

Game Based Learning in Neuroscience

650

Neuromodulation for Primary Headache - Part 4

651

Neuromodulation for Primary Headache - Part 3

652

AAN Summer Conference

653

Teratogenesis and Neurodevelopment on Antiseizure Medication: A Practice Guideline

654

Neurologic Diagnoses after COVID-19 or Influenza Hospitalization

655

These AI Hacks Could Alleviate Administrative Burden

656

Psychogenic Non-Epileptic Seizures - Part 3

657

Neuromodulation for Primary Headache - Part 2

658

Long-Term Follow-Up of the LEAP Study

659

Herpes Simplex Virus Encephalitis

660

Neuromodulation for Primary Headache - Part 1

661

Psychogenic Non-Epileptic Seizures - Part 2

662

Idiopathic Generalized Epilepsy - Part 5

663

Unrecognized Focal Non-Motor Seizures in Adolescents

664

sNfL and Radiologic Disease Activity in Patients With MS - Part 2

665

sNfL and Radiologic Disease Activity in Patients With MS - Part 1

666

Psychogenic Non-Epileptic Seizures - Part 1

667

Idiopathic Generalized Epilepsy - Part 4

668

Clinical Characteristics and Long-Term Outcomes of Late-Onset MS

669

Skin Biopsy Detection of Phosphorylated α-Synuclein

670

Idiopathic Generalized Epilepsy - Part 3

671

Pathogen Detection and Associated Patient Characteristics from Clinical Metagenomic Next-generation Sequencing Testing for Neurological Infections

672

Clinical Phenomenology Distinguishing Functional Tic-Like Behaviors from Primary Tics in Young People

673

Physicians as Patients Series - Arteriovenous Malformation Part 2

674

Idiopathic Generalized Epilepsy - Part 2

675

Robert Frost's Inaugural Woes: A Differential Diagnosis for his Acute Vision Loss

676

Physicians as Patients Series - Arteriovenous Malformation Part 1

677

Evaluation of the Diagnostic Utility of Caveolae-associated Protein 4 (cavin-4) Epitope-based ELISA in Identification of Immune Mediated Rippling Muscle Disease

678

Educating Child Neurology Residents About PNES

679

Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

680

Defining the CSF Cytokine and Chemokine Signature of Neurosarcoidosis

681

A Discussion with Dr. Avindra Nath: Ted Burns Humanism Award Winner - Part 2

682

Randomized Controlled Trial of iSTAND

683

Impact of Immune Checkpoint Inhibitors

684

Space Headaches Experienced by Astronauts

685

IGE Introduction - Part 1

686

Disability in NMOSD vs MOGAD

687

Updates on the NAEC Guidelines

688

Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

689

A Discussion with Dr. Avindra Nath: Ted Burns Humanism Award Winner - Part 1

690

The Role EEG Plays in the Clinical Practice

691

Early Identification of Candidates for Epilepsy Surgery

692

Brain Iron Accumulation in Participants with Acute Post-traumatic Headache

693

Effectiveness of Seizure Dogs

694

Neurodevelopmental and Functional Outcomes Following In Utero Exposure to Anti-Seizure Medication

695

Disclosing the Risk Associated with Isolated REM Behavior Disorder

696

Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia

697

Lecanemab in Alzheimer Disease

698

Clinical Assessment of Anti-IgLON5 Disease

699

Disparities in Genetic Testing for Neurologic Disorders

700

Seizure Dogs Reduce Frequency of Seizures, but Discontinuations are Common